Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting.

Ki Hong ChoiYoung Bin SongDong Seop JeongYong Ho JangDavid HongSang Yoon LeeTaeho YounMinjung BakKyung Min MinJoo Myung LeeTaek Kyu ParkJeong Hoon YangJoo-Yong HahnJin-Ho ChoiSeung-Hyuk ChoiSu Ryeun ChungYang Hyun ChoKiick SungWook Sung KimHyeon-Cheol GwonYoung Tak Lee

Published in: European heart journal. Cardiovascular pharmacotherapy (2022)

ClinicalTrials.gov, NCT03870815.

Keyphrases

antiplatelet therapy
acute coronary syndrome
percutaneous coronary intervention
coronary artery bypass grafting
end stage renal disease
coronary artery disease
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
prognostic factors
atrial fibrillation